Post-COVID-19 Dermatomyositis: A Delayed Reaction That Evades Early Detection

Dermatomyositis (DM) is a rare autoimmune disease that causes symmetrical and predominantly proximal muscle weakness in the limbs and typical skin lesions. Its prevalence increased during the coronavirus disease-2019 (COVID-19) pandemic. Viral infections may cause autoimmunity and trigger the pathog...

Descripción completa

Detalles Bibliográficos
Autores principales: MD HADIS, Nur Ili Syazwani, MOHD YUSOFF, Siti Suhaila, MUHAMAD, Rosediani, CHE JUHA, Fatin Hanani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500330/
https://www.ncbi.nlm.nih.gov/pubmed/36128859
http://dx.doi.org/10.4274/MMJ.galenos.2022.55890
Descripción
Sumario:Dermatomyositis (DM) is a rare autoimmune disease that causes symmetrical and predominantly proximal muscle weakness in the limbs and typical skin lesions. Its prevalence increased during the coronavirus disease-2019 (COVID-19) pandemic. Viral infections may cause autoimmunity and trigger the pathogenesis of myositis. We present the case of a man with a long history of myalgia and muscle weakness, who was initially diagnosed with post-COVID-19 myalgia and subsequently developed progressive muscle weakness. Biochemical and muscle biopsy results confirmed DM. The patient responded favorably to the course of steroid treatment.

Ejemplares similares